Psychedelics as Medicine: Expert Interview with Dr. Henrik Jungaberle in the “Psych Report 2021”
DO PSYCHEDELICS REALLY HAVE THE POWER TO DISRUPT HEALTHCARE? IF SO, HOW?
The Psychedelics as Medicine Report: Third Edition (2021) is an industry report outlet. It describes itself as “a premium business-to-business media and content platform for the psychedelic science and healthcare industry. Part of Psych Capital Plc.”. As such it tries to collect “consumer insights and market intelligence from experts and industry leaders, helping investors cut through the noise and identify real opportunities.”
Dr. Henrik Jungaberle has been interviewed for the report by Floris Wolswijk. Henrik is not involved with and has not been paid for the interview by either of the parties who produced or sponsored the report. His views are his own.
Conference: INSIGHT 2021 – an invitation to Berlin. Psychedelic research, therapy and drug development in Berlin
At INSIGHT 2021, scientists and therapists, pharmaceutical industry and anthropology, philosophers, and chemists will come together to determine the potential place of LSD, psilocybin, DMT, MDMA, and other psychedelic substances in the treatment of mental disorders. In addition, we will discuss the use of non-pharmacological methods to alter and cultivate states of consciousness and all that it takes to build such unusual states of consciousness a legitimate and safe place in society.
Podcast: Drugs are the answer to what question after all? Henrik Jungaberle in Wieprechts Truths
Drugs are the answer to what questions yet the same?
In a conversation with scientist and drug expert Henrik Jungaberle, Volker Wieprecht rethinks his plan to celebrate his 75th birthday with an opium intoxication. Why actually drugs and if so, for what purpose?
Wieprecht’s Wahrheiten is a podcast for everyone who wants to explore (with him) the deeper meaning of life.
Podcast: Henrik in conversation with Darek Dwanda on values and programs of the MIND Foundation
Berlin’s MIND Foundation is one of Europe’s largest psychedelic therapy organizations with global aspirations. MIND has a range of amazing programs for therapists, academics, and anyone else interested in new psychedelic therapies. In this episode we discuss a range of issues including European psychedelic landscape, ethics of Psychedelic-Assisted Therapies, cultural issues, issues of growth, and many other issues related to healing with psychedelics.
Gert Scobel diskutiert auf 3SAT über Drogen als Medizin – mit Franz Vollenweider, Thomas Metzinger und Magaly Tornay
Gert Scobel diskutiert auf 3SAT über Drogen als Medizin – mit Franz Vollenweider, Thomas Metzinger und Magaly Tornay
Gert Scobel discusses drugs as medicine on 3SAT – with Franz Vollenweider, Thomas Metzinger und Magaly Tornay
Gert Scobel discusses new therapies with hallucinogenic drugs with historian Magaly Tornay, psychiatrist Franz Vollenweider, and philosopher and neuroethicist Thomas Metzinger.
Medicine of Interactions – What modern Medicine could learn from its historical Encounter with “Animal Magnetism”
Whoever deals with the person, work and history of Franz Anton Mesmer is confronted with the difficulty of facing a personality whose many facets make it difficult to force him into a uniform image. Mesmer seems to evade this attempt to grasp him light-footedly, like one of his much-vaunted fluids.
Franz Anton Mesmer gave impulses for the most diverse disciplines and topoi. Examples are the development of anesthesia, psychiatry, psychosomatics, hypnotism and psycho-therapy. – For the sociological formation of the latter, his unintended influence should not be underestimated. Beyond that, however, his teachings had an effect in the fields of parapsy-chology, spiritualism, which returned to Europe via America, spiritual healing, stage hypno-sis, and in an extensive way in the history of literature, especially German Romanticism.
What can medicine learn from its encounter with “animal magnetism”? How would it react to esoteric and metaphysial theories that evolve around an otherwise “rational” and effective therapy TODAY?a